title: Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients.
authors.affiliation: Transplantation Institute, Warsaw Medical School, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Durlik
authors.forename: Z
authors.initials: Z
authors.lastname: Gaciong
authors.forename: L
authors.initials: L
authors.lastname: Soluch
authors.forename: B
authors.initials: B
authors.lastname: Walecka-Zielecka
authors.forename: Z
authors.initials: Z
authors.lastname: Rancewicz
authors.forename: D
authors.initials: D
authors.lastname: Rowińska
authors.forename: W
authors.initials: W
authors.lastname: Rowiński
authors.forename: J
authors.initials: J
authors.lastname: Szmidt
authors.forename: M
authors.initials: M
authors.lastname: Lao
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology* / Q000401:mortality; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies